NYSE: DPLO

+0.64 +2.3% $ 28.27 Volume: 842,794 Common Stock | 20 minute delay June 22, 2018

One Patient at a Time.

Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: ‘‘Take good care of patients, and the rest falls into place.’’ Today, that tradition continues and we have focused on creating a culture that is highly focused on improving patient care and clinical adherence.

We believe that our primary focus on the patient differentiates us from our competition. We understand that the primary concerns of a patient facing a chronic and serious condition are quality of care and ease of working with the pharmacy. We believe that our detailed, well managed, high-touch patient care program that is designed to address these concerns is essential to our success. Our specialty drug dispensing and services business model creates partnerships with patients, payors, pharmaceutical manufacturers and physicians—with a focus on improving adherence and the patient experience.

Date Filing Filing Description Download
December 8, 2015 4 Statement of Changes in Beneficial Ownership
December 2, 2015 4 Statement of Changes in Beneficial Ownership
December 1, 2015 4 Statement of Changes in Beneficial Ownership

NYSE: DPLO

+0.64 +2.3% $ 28.27 Volume: 842,794 Common Stock | 20 minute delay June 22, 2018

Investor Contact

Terri Anne Powers,
Vice President, Investor Relations
Diplomat Pharmacy Inc.
tpowers@diplomat.is
Phone: 312.889.5244

Email Now